Clinical trial for Long COVID
Official title Mind Body Intervention for Long COVID-19
ClinicalTrials.gov ID: NCT06045338
What this study is testing
- What it's testing
- This study is testing whether a mind-body practice reduces Long COVID symptoms. It also checks if it helps you do daily tasks better.
- Who it's for
- You may be able to join if you have Long COVID symptoms.
- What's involved
- You would be picked by chance to get a mind-body practice, a different practice, or usual care. You would take part in the chosen plan and share how you feel.
- Time commitment
- The source text does not say how long the study lasts or how many visits are needed.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adult (≥ 18 years of age)
- Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing)
- Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)
- A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains
- Symptoms present at least 3 day a week for a minimum of 3 months
You likely can't join if
- Clear diagnosis of physical disease (e.g. lung fibrosis, myocarditis) not inclusive of non-specific findings such as mild arthritis
- Hospitalization in an intensive care unit for acute COVID-19 infections
- Age greater than 65 years
- Diagnosis of dementia or similar cognitive impairment
- Active addiction disorder (e.g. cocaine) that would interfere with study participation
- Major psychiatric comorbidity (e.g., schizophrenia). Mild to moderate anxiety and depression are not considered in this category
See the full eligibility criteria
- Adult (≥ 18 years of age)
- Infection with Sars-COV2 (i. e., positive antibody, antigen, or PCR testing)
- Symptoms attributed only to COVID-19 and not to known comorbid disease (e.g., other infections, cancer, etc)
- A somatic symptom score ≥ 10 on the SSS-8 questionnaire with involvement of at least 3 domains
- Symptoms present at least 3 day a week for a minimum of 3 months
- Willingness to engage in a Mind-Body intervention
- Clear diagnosis of physical disease (e.g. lung fibrosis, myocarditis) not inclusive of non-specific findings such as mild arthritis
- Hospitalization in an intensive care unit for acute COVID-19 infections
- Age greater than 65 years
- Diagnosis of dementia or similar cognitive impairment
- Active addiction disorder (e.g. cocaine) that would interfere with study participation
- Major psychiatric comorbidity (e.g., schizophrenia). Mild to moderate anxiety and depression are not considered in this category
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.